# Effects of Dexmedetomidine and Dopamine on Renal Function After Major Surgery

> **NCT03170739** · PHASE4 · UNKNOWN · sponsor: **Tao Zhang** · enrollment: 180 (estimated)

## Conditions studied

- Renal Function

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Dopamine

## Key facts

- **NCT ID:** NCT03170739
- **Lead sponsor:** Tao Zhang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-06
- **Primary completion:** 2019-10
- **Final completion:** 2019-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2018-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03170739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03170739, "Effects of Dexmedetomidine and Dopamine on Renal Function After Major Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03170739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*